# A Phase 2 Extension of Study GCS-100-CS-4003

> **NCT02333955** · PHASE2 · WITHDRAWN · sponsor: **La Jolla Pharmaceutical Company**

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DRUG:** GCS-100

## Key facts

- **NCT ID:** NCT02333955
- **Lead sponsor:** La Jolla Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-01
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Corporate decision
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333955, "A Phase 2 Extension of Study GCS-100-CS-4003". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02333955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*